Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Xetra  >  Merck KGaA    MRK   DE0006599905

News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Merck KGaA : EMD Serono Joins Industry Leaders for The Economist Events' War On Cancer Forum in Boston

10/08/2015 | 04:27pm US/Eastern

By a News Reporter-Staff News Editor at Biotech Business Week -- EMD Serono announced that Merck KGaA, Darmstadt, Germany, is a platinum sponsor of The Economist Events' Health Care Forum: War on Cancer. The event brings together policymakers, oncology experts, researchers and pharmaceutical and insurance executives to engage in important dialogue on advancing cancer research and care through collaboration on September 29, 2015 in Boston (see also Biotechnology Companies).

"Over the last 10 years, the survival rates in many types of cancers as well as the number of potential oncology treatments in development have risen steadily, but cancer is a resilient enemy," said Paris Panayiotopoulos, President and Managing Director of EMD Serono. "The Economist Events' 'War on Cancer' Forum brings together key stakeholders with the goal of fostering collaboration and helping us identify new solutions that can one day benefit patients."

The American Cancer Society estimates that there will be more than 1.6 million new cancer cases diagnosed and nearly 590,000 cancer deaths in the U.S. this year. Five-year survival rates for many cancers are improving due, in part, to improved prevention, screening and therapy. However, there are still unmet needs, particularly in rare and difficult-to-treat cancers where there are fewer treatment options. The War on Cancer forum will explore which cancers are actually preventable, the importance of big data and the role that technology presents in altering people's behaviors for improved health, among other topics.

The Economist Events' War on Cancer forum is part of a global event series, the first of which took place in Hong Kong in March, with the final conference to be held in London in October. The Boston event will be chaired by The Economist's healthcare correspondent Natasha Loder.

For more information, click here. Join the conversation and connect with speakers and attendees on Twitter via #WarOnCancer.

Keywords for this news article include: Pharmaceutical Company, Cancer, Oncology, EMD Serono, Biotechnology Companies.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2015, NewsRx LLC

(c) 2015 NewsRx LLC, source Health Newsletters

React to this article
Latest news on MERCK KGAA
10/08 MERCK KGAA : EMD Serono Joins Industry Leaders for The Economist Events' War On ..
10/08 MERCK KGAA : Serono Announces Recipients of the Third Annual €1 Million Grant fo..
10/08 MERCK KGAA : Darmstadt, Germany, and Pfizer Announce FDA Orphan Drug Designation..
10/07 MERCK KGAA : and Pfizer Announce Investigational Immunotherapy Avelumab Receives..
10/05 BIOMARIN PHARMACEUTICAL : Merck Agrees to Return Kuvan Rights to BioMarin Pharma..
10/03 MERCK KGAA : Serono Awards Grant for Growth Innovation at ESPE in Barcelona
10/03 MERCK KGAA : Serono Awards Grant for Growth Innovation at ESPE in Barcelona
10/01DJBioMarin to Acquire Global Rights to the Drug Kuvan
10/01 MERCK KGAA : Presents Details on Immuno-Oncology Program Including First-in-Man ..
10/01 MERCK KGAA : Creates Greater Scope for Developing Ideas – Innovation Cente..
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Income Statement Evolution
More Financials